Synthesis of the optical isomers of a new anticholinergic drug, penehyclidine hydrochloride (8018).

[1]  B. Zhong,et al.  Studies on crystal structure of inclusion chiral crystal of (S)-α-cyclopentyl-α-hydroxyl-α-thienylacetic acid with (R)-α-methyl benylamine , 2004 .

[2]  Liron Levy,et al.  Trends in the development of chiral drugs. , 2004, Drug discovery today.

[3]  B. Zhong,et al.  Crystal Structure of (2S,5R)-2-(tert-Butyl)-5-phenyl-5-(cyclopentyl-1-ol)-1,3-dioxolan-4-one , 2004 .

[4]  Wei-dong Yu,et al.  Effects of pretreatment with 8018 on the toxicokinetics of soman in rabbits and distribution in mice. , 2003, Life sciences.

[5]  Pradeep Kumar,et al.  An asymmetric dihydroxylation route to (S)-oxybutynin , 2003 .

[6]  C. Ramana,et al.  A novel and simple asymmetric synthesis of CMI-977 (LDP-977): a potent anti-asthmatic drug lead , 2003 .

[7]  A. Rouhi.  CHIRAL BUSINESS: Fine chemicals companies are jockeying for position to deliver the increasingly complicated chiral small molecules of the future , 2003 .

[8]  J. Caldwell,et al.  Putting chirality to work: the strategy of chiral switches , 2002, Nature Reviews Drug Discovery.

[9]  Y. Ogino,et al.  Diastereoselective Synthesis of the Acid Part of a New Muscarinic M3 Receptor Antagonist , 2000 .

[10]  A. Satoh,et al.  A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors. , 2000, Journal of Medicinal Chemistry.

[11]  C. Senanayake,et al.  Chiral mandelic acid template provides a highly practical solution for (S)-oxybutynin synthesis. , 2000, The Journal of organic chemistry.

[12]  D. Hay.  Chronic obstructive pulmonary disease: emerging therapies. , 2000, Current opinion in chemical biology.

[13]  A. Satoh,et al.  J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors. , 1999, Bioorganic & medicinal chemistry.

[14]  Y. Ogino,et al.  Stereoselective synthesis of a new muscarinic M3 receptor antagonist, J-104129. , 1999, Bioorganic & medicinal chemistry letters.

[15]  P. Angeli.  Pentatomic cyclic antagonists and muscarinic receptors: a 30-year review. , 1998, Farmaco.

[16]  F. Knapp,et al.  Structure Elucidation Via Stereoselective Synthesis of the Acetate Center of 1-Azabicyclo[2.2.2]oct-3-yl alpha-Hydroxy- alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate (IQNP). A High Affinity Muscarinic Imaging Agent for SPECT. , 1996, The Journal of organic chemistry.

[17]  K. Goa,et al.  Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. , 1995, Drugs & aging.

[18]  D. Kiesewetter.  Asymmetric synthesis of benzilic acid analogues using 8-phenylmenthol as a chiral auxiliary , 1993 .

[19]  C. Behrens,et al.  Selective transformation of 2,3-epoxy alcohols and related derivatives. Strategies for nucleophilic attack at carbon-1 , 1985 .